Targeting Pioglitazone Hydrochloride Therapy After Stroke or Transient Ischemic Attack According to Pretreatment Risk for Stroke or Myocardial Infarction

IMPORTANCE: There is growing recognition that patients may respond differently to therapy and that the average treatment effect from a clinical trial may not apply equally to all candidates for a therapy. OBJECTIVE: To determine whether, among patients with an ischemic stroke or transient ischemic a...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:JAMA Neurol
Hlavní autoři: Kernan, Walter N., Viscoli, Catherine M., Dearborn, Jennifer L., Kent, David M., Conwit, Robin, Fayad, Pierre, Furie, Karen L., Gorman, Mark, Guarino, Peter D., Inzucchi, Silvio E., Stuart, Amber, Young, Lawrence H.
Médium: Artigo
Jazyk:Inglês
Vydáno: American Medical Association 2017
Témata:
Original Investigation
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5710663/
https://ncbi.nlm.nih.gov/pubmed/28975241
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaneurol.2017.2136
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky